Megan Lerner to Brain Neoplasms
This is a "connection" page, showing publications Megan Lerner has written about Brain Neoplasms.
Connection Strength
0.784
-
XRN2 Is Required for Cell Motility and Invasion in Glioblastomas. Cells. 2022 04 28; 11(9).
Score: 0.160
-
A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
Score: 0.156
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.136
-
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
Score: 0.111
-
In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed. 2012 Apr; 25(4):685-94.
Score: 0.077
-
Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy. Free Radic Biol Med. 2011 Jul 15; 51(2):490-502.
Score: 0.075
-
Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J Magn Reson Imaging. 2010 Aug; 32(2):267-75.
Score: 0.071